Left ventricular dysfunction and heart failure mechanistic and therapeutic distinctions

Keyphrases

• Heart Failure 100%
• Left Ventricular Dysfunction 100%
• Ventricular Remodeling 100%
• Vasodilator 33%
• Effective Therapy 33%
• Molecular Mechanism 33%
• Targeted Therapy 33%
• Beta-blockers 33%
• Left Ventricle 33%
• Cellular Mechanisms 33%
• Symptomatic Heart Failure 33%
• Diuretics 33%
• Aggressive Treatment 33%
• Hydralazine 33%
• Isosorbide Dinitrate 33%
• Early Recognition 33%
• Insults 33%
• Digoxin 33%
• Remodeling Process 33%
• Distinct Entity 33%
• End-stage Heart Disease 33%
• Ventricular Dysfunction 33%
• Angiotensin-converting Enzyme Inhibitor (ACEi) 33%

Medicine and Dentistry

• Heart Left Ventricle Failure 100%
• Heart Ventricle Remodeling 100%
• Congestive Heart Failure 100%
• Targeted Therapy 33%
• Heart Disease 33%
• Left Ventricle 33%
• ACE Inhibitor 33%
• Beta Adrenergic Receptor Blocking Agent 33%
• Isosorbide Dinitrate 33%
• Heart Ventricle Function 33%
• Digoxin 33%
• Hydralazine 33%
• Diuretics 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Heart Ventricle Remodeling 100%
• Congestive Heart Failure 100%
• Heart Left Ventricle Failure 100%
• Hydralazine 33%
• Beta Adrenergic Receptor Blocking Agent 33%
• Heart Disease 33%
• Dipeptidyl Carboxypeptidase Inhibitor 33%
• Isosorbide Dinitrate 33%
• Digoxin 33%
• Diuretics 33%